ANLN and bladder transitional cell carcinoma: Furthermore, ANLN was identified as a biomarker for the prognosis of bladder urothelial carcinoma (Zeng et al., 2017), colorectal cancer (Wang et al., 2016), and lung adenocarcinoma (Long et al., 2018).